Mood Disorders: Depression and Bipolar Disorder Explained

Neuroimaging studies show involvement of specific brain areas in depression. The hippocampus shows volume reduction correlated with cognitive symptoms. The prefrontal cortex and amygdala show dysfunctions correlating with somatic and affective symptoms. Functional neuroimaging shows decreased activity in the dorsolateral prefrontal cortex (cognitive symptoms) and increased activity in the amygdala and ventromedial prefrontal cortex (affective symptoms). The vulnerability phenotype concept explains how genetic predisposition combined with early adverse experiences creates biological vulnerability through HPA axis hyperactivation and neurotoxicity.

Bipolar disorder is a complex mental health condition characterized by extreme mood swings between mania and depression, involving dysregulation of key neurotransmitters (dopamine, serotonin, noradrenaline, glutamate, and GABA) and affecting multiple brain structures including the prefrontal cortex, amygdala, hippocampus, nucleus accumbens, and thalamus, with risk factors including genetic predisposition, environmental stressors, trauma, substance abuse, and hormonal imbalances.

Major depressive disorder and bipolar disorder are characterized by a complex interplay of neurodevelopmental and neurodegenerative processes, involving genetic liability (30-75%), epigenetic modifications, neuroinflammation, glutamate-GABA imbalances, and disturbances in brain-derived neurotrophic factor and cellular bioenergetics; these conditions manifest as disconnection syndromes where abnormal functional connectivity between brain circuits—particularly between the default mode network and task-positive networks—leads to impaired cognitive efficiency, emotional dysregulation, and reduced top-down cortical control over subcortical structures, with treatments potentially working by restoring normal circuit segregation, integration, and reciprocity.

The amygdala is a brain structure involved in processing emotions, particularly fear and negative emotions. The medial prefrontal cortex has strong connections with the amygdala and is involved in emotional regulation. Research has shown that people with certain genetic predispositions to depression may have enlarged amygdalae and reduced thickness in the medial prefrontal cortex.

Depression involves deficiencies in noradrenaline, dopamine, and serotonin, with reduced GABAergic stimulation and increased glutamatergic activity. Bipolar disorder shows alterations in the prefrontal cortex, cerebellum, and limbic system with increased noradrenaline and serotonin, affecting mood, motor activity, appetite, and sleep. Both disorders have significant genetic components, with family history being an important diagnostic consideration.

Mood disorders such as depression and bipolar disorder frequently co-occur with anxiety disorders (including generalized anxiety disorder, OCD, PTSD, panic disorder, and social phobia), personality disorders (particularly borderline personality disorder), and eating disorders (anorexia and bulimia), with approximately 80% of bipolar disorder patients developing at least one anxiety disorder; this comorbidity significantly worsens clinical outcomes, increases suicide risk, and complicates treatment, requiring careful differential diagnosis and integrated treatment approaches that prioritize mood stabilization while addressing associated conditions.

This comprehensive section examines anxiety and mood disorders that frequently co-occur with eating disorders. Anxiety disorders include generalized anxiety (persistent uncontrolled worry), social anxiety (fear of evaluation), panic disorder (sudden intense anxiety attacks), and OCD (intrusive thoughts requiring compulsions). Mood disorders covered are major depressive disorder (chronically low mood preventing functioning) and bipolar disorder (alternating depressive and manic episodes). The section explains comorbidity - having multiple disorders simultaneously - with almost all anxiety disorders increased among eating disorder populations. Shared mechanisms include biological/genetic predispositions toward rapid aversive conditioning, overlapping cognitive patterns of perceiving danger, and emotional dysregulation (inability to modulate emotions). Depression frequently occurs secondary to eating disorders, meaning treating the eating disorder often improves depression simultaneously.

Mental health is the balance between internal resources and external demands across professional, social, affective, familial, financial, and physical dimensions. The brain commands the entire organism, making mental health the most important health. Major Depressive Disorder involves depressive episodes that can be single or recurring. Bipolar Affective Disorder includes both depressive and manic episodes, encompassing Major Depressive Disorder. These disorders result from altered neuronal communication, genetic predisposition, and environmental stressors. Genetic factors are crucial: if one parent has bipolar disorder, the child has a 40% chance of developing it. Comorbidity refers to the presence of two or more diseases in the same patient, including anxiety disorders, personality disorders, eating disorders, medical conditions, ADHD, conduct disorder, and substance abuse. Anxiety disorders have elevated prevalence in bipolar disorder (2.38 times higher than in depression), with up to 80% of bipolar patients developing an anxiety disorder. Substance abuse comorbidity with bipolar disorder is very high, with frequent diagnostic confusion. Patients with bipolar disorder have higher chances of substance use, and substance use worsens the bipolar disorder, creating a vicious cycle.

Mood disorders encompass depressive disorders (major depression, persistent depressive disorder, premenstrual dysphoric disorder) and bipolar disorders (type 1, type 2, cyclothymia). Comorbidity is common, with anxiety frequently accompanying depression. Diagnostic challenges include distinguishing ADHD from depression, differentiating hypomania from personality traits, and recognizing that bipolar disorder often takes up to 10 years to diagnose correctly. Family input and thorough history-taking are essential for accurate diagnosis.

Eating disorders frequently co-occur with other mental health conditions including depression, anxiety disorders, and substance use disorders. This comorbidity complicates treatment and requires comprehensive approaches. Effective treatment typically involves a combination of psychiatric evaluation, nutritional counseling, and psychotherapy. Cognitive-behavioral therapy (CBT) and other evidence-based treatments focus on addressing the thoughts and behaviors that maintain disordered eating patterns.

Accurate diagnosis of bipolar disorder requires distinguishing it from similar conditions. ADHD typically manifests before age 7 with persistent daily symptoms of inattention and hyperactivity, lacking the episodic nature of bipolar disorder. Borderline personality disorder differs through earlier onset (adolescence), shorter depressive episodes lasting hours to days, and characteristic emotional emptiness driving self-harm behaviors. Key differentiators include: BPD involves identity disturbances and abandonment fears; bipolar features distinct mood episodes with creative potential during hypomania; BPD involves brief paranoid ideation post-loss. Understanding these distinctions guides appropriate treatment selection.

Bipolar disorder is frequently misdiagnosed and confused with several other psychiatric conditions including Borderline Personality Disorder (characterized by rapid mood changes lasting hours/days and relationship instability without true manic episodes), Schizophrenia (distinguished by persistent emotional flattening, social withdrawal, and progressive cognitive impairment versus bipolar's time-limited psychotic features during mood episodes), ADHD (where attention problems and impulsivity occur exclusively during manic/mixed episodes rather than persisting from childhood), and Major Depressive Disorder (where treating bipolar depression with antidepressants alone can trigger rapid cycling and worsen outcomes); accurate differential diagnosis is crucial because misdiagnosis leads to inappropriate treatment, delayed proper intervention, and potentially severe consequences for patients.

Bipolar Disorder and Borderline Personality Disorder share overlapping symptoms such as mood swings, impulsivity, and relationship difficulties, but key differences exist: Bipolar Disorder involves distinct episodic highs (manic/hypomanic episodes lasting 4+ days) and lows with periods of stable functioning, responds well to medication, and typically begins around age 18; Borderline Personality Disorder involves persistent instability throughout life, with symptoms triggered by abandonment fears and rejection sensitivity, showing less response to medication, and often begins earlier in adolescence. The critical distinction lies in medication responsiveness—medication effectively treats bipolar surface symptoms (mood episodes, anxiety, psychosis) but does not address BPD core content (abandonment fears, rejection sensitivity, feelings of emptiness).

Bipolar disorder and borderline personality disorder are frequently misdiagnosed due to overlapping symptoms of emotional dysregulation; bipolar disorder involves biologically-driven mood episodes lasting weeks to months without clear external triggers, while borderline personality disorder features intense, disproportionate emotional reactions to environmental or psychosocial triggers, with treatment responses differing significantly—bipolar typically responds well to psychopharmacology while BPD requires intensive psychotherapy.

Bipolar disorder and borderline personality disorder can be distinguished by their underlying nature: bipolar disorder is a psychiatric illness characterized by episodic mood episodes lasting at least two weeks (depression) or one week (mania), while borderline personality disorder is a personality disorder involving persistent patterns of unstable relationships, self-image, and emotional expression that manifest as rapid, hour-to-hour mood shifts and chronic behavioral issues; treatment also differs, with dialectical behavioral therapy (DBT) being the primary treatment for BPD and medication management for bipolar disorder.